Benign Infantile Epilepsy Gene Panel Test
At DNA Labs UAE, we offer the Benign Infantile Epilepsy Gene Panel Test to screen for mutations in genes associated with benign infantile epilepsy (BIE). This genetic test helps in diagnosing and understanding the symptoms of BIE.
Test Details
The Benign Infantile Epilepsy Gene Panel Test is a genetic test that screens for mutations in genes associated with benign infantile epilepsy (BIE). BIE is a type of epilepsy that typically occurs in infants between 3 and 12 months of age and is characterized by brief, self-limiting seizures that do not cause long-term neurological damage.
The panel typically includes genes such as KCNQ2, KCNQ3, SCN2A, and SCN8A, which are known to be associated with BIE. Mutations in these genes can cause disruptions in the electrical activity of the brain, leading to seizures.
Test Components
- Sterile container
- Sterile Normal Saline Container
- EDTA Vacutainer
Price
The cost of the Benign Infantile Epilepsy Gene Panel Test is 7200.0 AED.
Sample Condition
The test can be performed using samples of amniotic fluid, chorionic villi, or peripheral blood.
Report Delivery
Results from the test are typically delivered within 4-6 weeks.
Method
The Benign Infantile Epilepsy Gene Panel Test is performed using Next Generation Sequencing (NGS) technology.
Test Type
The test falls under the category of Genetics.
Doctor
The test can be ordered by a General Physician.
Test Department
The test is conducted in our specialized Test Department.
Pre Test Information
The Benign Infantile Epilepsy Gene Panel Test requires a doctor’s prescription. However, it is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Conclusion
The Benign Infantile Epilepsy Gene Panel Test is an essential tool for diagnosing and understanding the genetic factors associated with benign infantile epilepsy. While the test can identify mutations in genes associated with BIE, it is important to note that not all cases of BIE are caused by genetic mutations. Other factors, such as environmental factors or developmental abnormalities, may also play a role in the development of BIE.
Test Name | Benign Infantile Epilepsy Gene Panel Test |
---|---|
Components | Sterile container/ Sterile Normal Saline Container/ EDTA Vacutainer |
Price | 7200.0 AED |
Sample Condition | Amniotic fluid\/ Chorionic villi\/ Peripheral blood |
Report Delivery | 4-6 weeks |
Method | NGS |
Test type | Genetics |
Doctor | General Physician |
Test Department: | |
Pre Test Information | Benign Infantile Epilepsy Gene Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details | The Benign Infantile Epilepsy Gene Panel is a genetic test that screens for mutations in genes associated with benign infantile epilepsy (BIE). BIE is a type of epilepsy that typically occurs in infants between 3 and 12 months of age and is characterized by brief, self-limiting seizures that do not cause long-term neurological damage. The panel typically includes genes such as KCNQ2, KCNQ3, SCN2A, and SCN8A, which are known to be associated with BIE. Mutations in these genes can cause disruptions in the electrical activity of the brain, leading to seizures. The test is typically performed using a blood or saliva sample and can be ordered by a healthcare provider. Results from the test can help to confirm a diagnosis of BIE and may also inform treatment decisions. It is important to note that while the Benign Infantile Epilepsy Gene Panel can identify mutations in genes associated with BIE, not all cases of BIE are caused by genetic mutations. Other factors, such as environmental factors or developmental abnormalities, may also play a role in the development of BIE. |